Back to top

Medpace Backs Shockwave’s New Carotid Device Study, Signaling Fresh Upside in Vascular Innovation

Medpace Holdings Inc ($MEDP) announced an update on their ongoing clinical study. The SKYWARD Trans-Femoral IDE study is a prospective, multi-cente...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Medpace Holdings, Inc. (MEDP)